Overview

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety of the oral formulation of levocetirizine in children ages 1 to less than 6 years old who suffer from allergic rhinitis or chronic urticaria of unknown origin.

Phase:

Phase 3

Details

Lead Sponsor:

UCB Pharma

Treatments:

Cetirizine
Levocetirizine